Sandoz Group AG (0SAN)
LSE
Closed
Aug 24, 2026
Day's Range
72.7652 wk Range
44.01Overview - 0SAN - Sandoz Group AG
Key Statistics
Valuation
Enterprise Value
28.79B
Price / Book
‪4.47‬
EV / EBITDA
‪22.89‬
Profitability
Profit Margin
‪5.53%‬
Operating Margin
‪4.25%‬
Return on Assets
‪3.06%‬
Return on Equity
‪7.24%‬
Ownership
Float
416.43M
Held by Insiders
‪4.18%‬
Held by Institutions
‪50.56%‬
Price stats
Beta
‪0.49‬
50-Day Avg
‪28.45‬
200-Day Avg
‪27.26‬
Dividends
Frequency
Annual
Peers - 0SAN - Sandoz Group AG
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- 0SANLSESandoz Group AG+33.88%52-week change—P/E (Trailing)‪8.19%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB+37.04%52-week change47.34P/E (Trailing)‪15.54%‬Profit Margin
- 0LERLSETeva Pharmaceutical Industries Ltd. ADR+49.95%52-week change29.67P/E (Trailing)‪51.78%‬Profit Margin
- PXSLSEProvexis plc+35.74%52-week change-6225.00P/E (Trailing)‪-69.30%‬Profit Margin
- CRDLLSECordel Group Plc+49.39%52-week change-6500.00P/E (Trailing)‪-27.15%‬Profit Margin
- 0AAJLSEPolyPeptide Group AG+54.34%52-week change0.30P/E (Trailing)‪-5.43%‬Profit Margin
- SEMGLSEAmundi MSCI Semiconductors UCITS ETF Acc+43.58%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - 0SAN - Sandoz Group AG
About
Sandoz Group AG is a Swiss company specializing in generic pharmaceuticals and biosimilars. It serves as the global leader in providing affordable generic and biosimilar medicines, with a purpose centered on pioneering access to treatments for patients worldwide. The company develops, manufactures, and commercializes…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
